Home Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study
Article
Licensed
Unlicensed Requires Authentication

Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study

  • Paula Grönroos , Olli T. Raitakari , Mika Kähönen , Nina Hutri-Kähönen , Jukka Marniemi , Jorma Viikari and Terho Lehtimäki
Published/Copyright: May 7, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 5

Abstract

Background: We examined the influence of apolipoprotein E (apoE) polymorphism on longitudinal changes in serum lipids by following the subjects participating in The Cardiovascular Risk in Young Finns Study over a 21-year period.

Methods: Serum lipids were determined in randomly selected Finnish children and adolescents in 1980 and the subjects were re-examined in 1983, 1986 and after 21 years in 2001. ApoE polymorphism was determined in 1736 participants, and serum lipid values and apoE phenotypes were available for 1233 subjects.

Results: ApoE phenotype-related differences in serum total and low-density lipoprotein (LDL)-cholesterol were maintained throughout the 21-year follow-up from childhood to adulthood, i.e., the apoE ɛ2 allele was consistently associated with lower and the ɛ4 allele with higher total and LDL-cholesterol (p<0.001 for all). In adulthood, there was also a significant apoE phenotype-related difference in high-density lipoprotein (HDL)-cholesterol (p=0.007), and the ɛ2 allele was associated with higher and the ɛ4 allele with lower apoA-I and HDL-cholesterol. In addition, apoB increased in the phenotype order E3/2<E3/3<E4 (E4/3+E4/4) (p<0.001). The LDL-lowering effect of the ɛ2 allele was greater in adulthood than in childhood, i.e., there was a significant apoE phenotype×time interaction (p=0.039) with longitudinal change in LDL-cholesterol.

Conclusions: ApoE polymorphism is associated with lipid levels at different ages and affects the longitudinal change in LDL-cholesterol from childhood to adulthood.

Clin Chem Lab Med 2007;45:592–8.


Corresponding author: Paula Grönroos, MD, PhD, Department of Clinical Chemistry, University of Turku, Kiinamyllynkatu 4-8, PO Box 52, 20521 Turku, Finland Phone: +358-400-937460, Fax: +358-2-3133924,

Received: 2006-12-21
Accepted: 2007-2-11
Published Online: 2007-05-07
Published in Print: 2007-05-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. 6th Conference on Homocysteine Metabolism, World Congress on Hyperhomocysteinemia, Saarbruecken/Germany June 5-9, 2007
  2. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes
  3. Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
  4. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study
  5. Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels
  6. Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions
  7. HLA-DQA1 and -DQB1 allele typing in southern Taiwanese women with breast cancer
  8. Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol
  9. Frequency of two human glutathione-S-transferase omega-1 polymorphisms (E155 deletion and E208K) in Ovambo and Japanese populations using the PCR-based genotyping method
  10. Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case
  11. Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients
  12. Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
  13. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome
  14. A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry
  15. Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats
  16. Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
  17. Measurement of calcitonin by immunoassay analyzers
  18. Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X
  19. Quality indicators and specifications for key processes in clinical laboratories: a preliminary experience
  20. Analytical and clinical performance of three natriuretic peptide tests in the emergency room
  21. Quality of serum creatinine measurement in light of EQA programs
  22. Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias
  23. Comparison between AlaTOP and IP8 inhalant panels on the Immulite 2000 analyzer
  24. External quality assessment of urinary methylmalonic acid quantification – results of a pilot study
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.116/pdf
Scroll to top button